These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15746033)

  • 1. Thrombopoietic factors in chronic bone marrow failure states: the platelet problem revisited.
    Kurzrock R
    Clin Cancer Res; 2005 Feb; 11(4):1361-7. PubMed ID: 15746033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and treatment of severe and prolonged thrombocytopenia in neonates.
    Sola MC
    Clin Perinatol; 2004 Mar; 31(1):1-14. PubMed ID: 15183652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
    Townsley DM; Desmond R; Dunbar CE; Young NS
    Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.
    Weisdorf DJ; DeFor T; Nichol J; Panoskaltsis-Mortari A; Blazar BR
    Bone Marrow Transplant; 2000 Apr; 25(7):711-5. PubMed ID: 10745255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia.
    Maslak P; Nimer SD
    Semin Hematol; 1998 Jul; 35(3):253-60. PubMed ID: 9685171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thrombocytopenia in bone marrow failure: a review.
    Salacz ME; Lankiewicz MW; Weissman DE
    J Palliat Med; 2007 Feb; 10(1):236-44. PubMed ID: 17298272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietic factors potentially useful in the treatment of acute leukemia.
    Archimbaud E; Thomas X
    Leuk Res; 1998 Dec; 22(12):1155-64. PubMed ID: 9922079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities for the use of thrombopoietic growth factors.
    Schiffer CA
    Stem Cells; 1998; 16 Suppl 2():249-53. PubMed ID: 11012197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.
    Tsimberidou AM; Giles FJ; Khouri I; Bueso-Ramos C; Pilat S; Thomas DA; Cortes J; Kurzrock R
    Ann Oncol; 2005 Jan; 16(1):139-45. PubMed ID: 15598951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
    Marsh JC; Ganser A; Stadler M
    Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia in myelodysplastic syndromes and myelofibrosis.
    Boruchov AM
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S37-43. PubMed ID: 19245933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietic growth factors and cytokines.
    Vadhan-Raj S; Cohen V; Bueso-Ramos C
    Curr Hematol Rep; 2005 Mar; 4(2):137-44. PubMed ID: 15720963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
    Giannini EG
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1055-65. PubMed ID: 16611265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the development of platelet growth factors: low expectations for low counts.
    Brown JR; Demetri GD
    Curr Hematol Rep; 2002 Nov; 1(2):110-8. PubMed ID: 12901132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines for the treatment of thrombocytopenia.
    Ciurea SO; Hoffman R
    Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.